{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T07:57:29Z","timestamp":1757577449779},"reference-count":35,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T00:00:00Z","timestamp":1362700800000},"content-version":"vor","delay-in-days":8681,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Clinical Pharma"],"published-print":{"date-parts":[[1989,6]]},"abstract":"<jats:p>A new generation of dihydropyridine calcium antagonists which are related structurally to nifedipine is undergoing clinical investigation. Among these newer agents, nicardipine and nimodipine have become available for clinical use. In controlled trials, nicardipine is superior to placebo and equal to other antihypertensive agents for the treatment of systemic hypertension. Nicardipine is associated with a low incidence of adverse effects that are related primarily to its peripheral vasodilatory actions. In addition, nicardipine appears to have little if any negative effects on myocardial contractility or conduction.<\/jats:p>","DOI":"10.1002\/j.1552-4604.1989.tb03368.x","type":"journal-article","created":{"date-parts":[[2013,3,8]],"date-time":"2013-03-08T22:34:22Z","timestamp":1362782062000},"page":"481-487","source":"Crossref","is-referenced-by-count":18,"title":["New Therapeutic Modalities in Hypertension: Focus on a New Calcium Antagonist\u2014Nicardipine"],"prefix":"10.1002","volume":"29","author":[{"given":"William H.","family":"Frishman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,3,8]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/archinte.1988.00380050029006","article-title":"The 1988 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure","volume":"148","author":"The Expert Panel: 1988 Joint National Committee","year":"1988","journal-title":"Arch Intern Med"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198734050-00005"},{"key":"e_1_2_1_4_2","first-page":"333P","article-title":"Comparative calcium entry blocking properties of nicardipine, nifedipine and PY\u2010108068 on cardiac and vascular smooth muscle","volume":"79","author":"Clarke B","year":"1983","journal-title":"Br J Pharmacol"},{"key":"e_1_2_1_5_2","first-page":"437P","article-title":"Cardioselective calcium entry blocking properties of a nicardipine metabolite","volume":"83","author":"Clarke B","year":"1984","journal-title":"Br J Pharmacol"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1985.tb05140.x"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(85)90130-4"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1986.tb00338.x"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(87)80209-7"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(86)90280-8"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(87)90790-3"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198409000-00015"},{"key":"e_1_2_1_13_2","first-page":"304","article-title":"Calcium antagonism free of negative inotropic effects: A comparison of intracoronary nifedipine and nicardipine","volume":"70","author":"Rousseau MF","year":"1984","journal-title":"Circulation"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1986.tb00329.x"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1985.tb05153.x"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1985.tb05156.x"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1985.tb05154.x"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1986.tb00334.x"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1985.tb05155.x"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198511000-00021"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.63.740.463"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1986.tb00332.x"},{"key":"e_1_2_1_23_2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1742-1241.1986.tb08045.x","article-title":"Comparative effects of nicardipine hydrochloride and hydrochlorothiazide in the treatment of mild to moderate hypertension: A double\u2010blind parallel study","volume":"40","author":"Creytens G","year":"1986","journal-title":"Br J Clin Pract"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1986.tb00328.x"},{"key":"e_1_2_1_25_2","first-page":"191","article-title":"Nicardipine and hydrochlorothiazide in essential hypertension","volume":"39","author":"Fagan TC","year":"1986","journal-title":"Clin Pharmacol Ther"},{"key":"e_1_2_1_26_2","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1742-1241.1986.tb07924.x","article-title":"A general practice trial of antihypertensive therapy comparing a combination of nicardipine and chlorthalidone with atenolol and chlorthalidone","volume":"40","author":"Douglas\u2010Jones AP","year":"1986","journal-title":"Br J Clin Pract"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00610373"},{"key":"e_1_2_1_28_2","first-page":"636P","article-title":"Efficacy and acceptability of twice daily nicardipine and propranolol in mild to moderate hypertension","volume":"25","author":"MacLean D","year":"1988","journal-title":"Br J Clin Pharmacol"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1177\/030006058701500401"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1986.tb00330.x"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00544554"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00610374"},{"key":"e_1_2_1_33_2","first-page":"727","article-title":"Clinical trial of a new antihypertensive drug, nicardipine: Efficacy and tolerance in 29,104 patients","volume":"42","author":"Dubois C","year":"1987","journal-title":"Curr Ther Res"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-198712000-00010"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005344-198609000-00002"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1987.137"}],"container-title":["The Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fj.1552-4604.1989.tb03368.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/j.1552-4604.1989.tb03368.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T12:31:18Z","timestamp":1697977878000},"score":1,"resource":{"primary":{"URL":"https:\/\/accp1.onlinelibrary.wiley.com\/doi\/10.1002\/j.1552-4604.1989.tb03368.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1989,6]]}},"alternative-id":["10.1002\/j.1552-4604.1989.tb03368.x"],"URL":"https:\/\/doi.org\/10.1002\/j.1552-4604.1989.tb03368.x","archive":["Portico"],"relation":{},"ISSN":["0091-2700","1552-4604"],"issn-type":[{"value":"0091-2700","type":"print"},{"value":"1552-4604","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,6]]}}}